Protagonist: Crohn's disease recurrence can be prevented after ileal resection
- PMID: 12117870
- PMCID: PMC1773309
- DOI: 10.1136/gut.51.2.152
Protagonist: Crohn's disease recurrence can be prevented after ileal resection
Comment in
-
Antagonist: Crohn's disease recurrence can be prevented after ileal resection.Gut. 2002 Aug;51(2):153-4. doi: 10.1136/gut.51.2.153. Gut. 2002. PMID: 12117871 Free PMC article. No abstract available.
Similar articles
-
Antagonist: Crohn's disease recurrence can be prevented after ileal resection.Gut. 2002 Aug;51(2):153-4. doi: 10.1136/gut.51.2.153. Gut. 2002. PMID: 12117871 Free PMC article. No abstract available.
-
Strategies for the prevention of postoperative recurrence of Crohn's disease.Colorectal Dis. 2013 Dec;15(12):1471-80. doi: 10.1111/codi.12326. Colorectal Dis. 2013. PMID: 23809911 Review.
-
[Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].Tunis Med. 2006 Oct;84(10):595-8. Tunis Med. 2006. PMID: 17193847 Review. French.
-
Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.Am J Gastroenterol. 2009 Aug;104(8):2089-96. doi: 10.1038/ajg.2009.301. Epub 2009 Jun 30. Am J Gastroenterol. 2009. PMID: 19568226 Review.
-
Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence.J Crohns Colitis. 2015 Aug;9(8):617-24. doi: 10.1093/ecco-jcc/jjv076. Epub 2015 Apr 29. J Crohns Colitis. 2015. PMID: 25926532 Clinical Trial.
Cited by
-
Rare and Serious Adverse Effects of Anti-Tumor Necrosis Factor-Alpha (TNF-α) Agents in Crohn's Disease.Cureus. 2021 Apr 30;13(4):e14768. doi: 10.7759/cureus.14768. Cureus. 2021. PMID: 34094733 Free PMC article.
-
High Incidence of Recurrent Crohn's Disease Following Colectomy for Ulcerative Colitis Revealed with Long Follow-Up.Dig Dis Sci. 2018 Feb;63(2):446-451. doi: 10.1007/s10620-017-4873-7. Epub 2017 Dec 28. Dig Dis Sci. 2018. PMID: 29282640
-
Novel 5-HT7 receptor antagonists modulate intestinal immune responses and reduce severity of colitis.Am J Physiol Gastrointest Liver Physiol. 2024 Jul 1;327(1):G57-G69. doi: 10.1152/ajpgi.00299.2023. Epub 2024 May 7. Am J Physiol Gastrointest Liver Physiol. 2024. PMID: 38713616 Free PMC article.
-
Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.Cochrane Database Syst Rev. 2019 Jun 20;6(6):CD008414. doi: 10.1002/14651858.CD008414.pub3. Cochrane Database Syst Rev. 2019. PMID: 31220875 Free PMC article.
-
Does microscopic involvement of the surgical margins after ileocecectomy in Crohn's patients predict early recurrence?Int J Colorectal Dis. 2021 Nov;36(11):2427-2435. doi: 10.1007/s00384-021-03941-7. Epub 2021 Apr 29. Int J Colorectal Dis. 2021. PMID: 33928416
References
-
- Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99:956–63. - PubMed
-
- Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology 1998;115:259–67. - PubMed
-
- Moskovitz D, McLeod RS, Greenberg GR, et al. Operative and environmental risk factors for recurrence of Crohn's disease. Int J Colorectal Dis 1999;14:224–6. - PubMed
-
- Caprilli R, Andreoli A, Capurso L, et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther 1994;8:35–43. - PubMed
-
- McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995;109:404–13. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical